Adapthealth Corp Stock Price, News & Analysis

AdaptHealth (NASDAQ: AHCO) said S&P Global Ratings upgraded its issue-level rating on the company’s senior unsecured debt to BB- from B+ and raised its recovery rating to 4 from 5.

S&P attributed the upgrade to $225 million of year-to-date prepayment on the senior secured term loan A due 2029, which S&P said improves recovery prospects for unsecured noteholders. Management noted it reduced term loan A by $275 million since end of Q3 2024 using free cash flow and proceeds from non-core asset dispositions.

AdaptHealth (NASDAQ: AHCO) reported third-quarter 2025 results for the period ended September 30, 2025. Net revenue was $820.3M, up 1.8% year-over-year, with organic revenue +5.1%. Net income was $24.5M versus $22.9M a year earlier and Adjusted EBITDA was $170.1M, up 3.5%. The company reduced debt by $50.0M in the quarter and $225.0M year-to-date, leaving net leverage at 2.68x vs a stated target of 2.50x. Year-to-date operating cash flow was $418.6M and free cash flow was $140.1M (down from $162.7M prior year). Registered myApp users rose to 271,000 from 118,000. Guidance for FY2025 was maintained: Net revenue $3.18B–$3.26B, Adj. EBITDA $642M–$682M, FCF $170M–$190M.

AdaptHealth (NASDAQ: AHCO) will participate in the UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday, November 11, 2025, including a fireside chat at 1:15 p.m. ET. A webcast link will be available on the company’s Investor Relations page at www.adapthealth.com.

AdaptHealth provides home medical equipment, supplies and related services across four reportable segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. The company serves beneficiaries of Medicare, Medicaid and commercial payors and reached approximately 4.2 million patients annually through about 660 locations in 47 states.

AdaptHealth (NASDAQ: AHCO) will release third quarter 2025 financial results before market open on Tuesday, November 4, 2025. Management will host a teleconference at 8:30 a.m. ET for analysts and investors to discuss results and business activities. Participants may dial (800) 343-4849 (Domestic) or (203) 518-9848 (International) and reference Conference ID: AHCO2Q25.

A webcast requires registration and a replay will be available for six months on the company's Investor Relations site at www.adapthealth.com.

AdaptHealth Corp. (NASDAQ: AHCO), a national leader in healthcare-at-home solutions, will participate in the Jefferies Healthcare Services Conference in Nashville on September 29, 2025. The company will engage in a fireside chat at 11:30 a.m. CST, with the webcast available on their website.

AdaptHealth operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through 630 locations in 47 states. The company partners with various healthcare providers and serves Medicare, Medicaid, and commercial insurance beneficiaries.

AdaptHealth (NASDAQ: AHCO), a national healthcare-at-home solutions provider, reported Q2 2025 financial results with net revenue of $800.4M, down 0.7% year-over-year. The company posted net income of $14.7M, compared to $19.4M in Q2 2024, and Adjusted EBITDA of $155.5M, a 5.9% decrease.

The company updated its FY2025 guidance, projecting revenue of $3.18B to $3.26B and Adjusted EBITDA of $642M to $682M. Notable achievements include completing sales of certain incontinence and infusion assets, improving cash flow from operations to $257.5M, and securing a new capitated partnership with a major national healthcare system.

AdaptHealth (NASDAQ: AHCO) has secured a significant 5-year exclusive partnership with a major national healthcare system to provide home medical equipment and supplies. The agreement, structured primarily as a capitation payment model, will serve over 10 million members across Medicare Advantage, Medicaid Managed Care, and privately insured patients.

AdaptHealth, which currently serves approximately 4.2 million patients annually through 630 locations in 47 states, will expand its reach through this partnership. The company operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, providing essential medical equipment and services to patients nationwide.

AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, announced its participation in the Canaccord Genuity 45th Annual Growth Conference in Boston. The company will engage in a fireside chat on Wednesday, August 13, 2025, at 8:00 AM ET.

AdaptHealth operates across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through 660 locations in 47 states. The company partners with various healthcare providers and serves Medicare, Medicaid, and commercial insurance beneficiaries.

AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, before market open.

The company will host an earnings conference call at 8:30 a.m. ET on the same day. Investors can join via phone using the numbers (800) 343-4136 (Domestic) or (203) 518-9843 (International) with Conference ID: AHCO2Q25. A webcast replay will be available on AdaptHealth's investor relations website for six months following the live call.